On Air Now

Upcoming Shows

Program Schedule »


Listen Live Now » 1330 AM Sheboygan, WI


Current Conditions(Sheboygan,WI 53081)

More Weather »
79° Feels Like: 82°
Wind: NE 5 mph Past 24 hrs - Precip: 0”
Current Radar for Zip


Partly Cloudy 75°


Thunderstorms Early 65°


Cloudy 72°


Breaking News

State Senator Joe Leibham to not seek recount for last week's election

SHEBOYGAN, WI (WHBL) - Joe Leibham will not seek a recount for last week's 6th House District Republican primary. The Sheboygan state senator lost the four man race to State Senator Glenn Grothman by 219 votes, which was close enough to ask for a recount that would have been paid for by local government units. In a statement made Friday afternoon, Leibham said he has contacted Grothman about his decision and wished him well in the November general election.  He adds he is happy of the ...

Read More »

Germany's Merck Serono to produce medicines in UAE

By Stanley Carvalho

ABU DHABI (Reuters) - Germany's Merck Serono said it would team up with an Abu Dhabi firm to produce medicines for the domestic and regional markets, the first multinational of its kind to make branded products in the United Arab Emirates.

Merck Serono, the pharmaceutical arm of Merck KGaA, will initially produce two of its products at Neopharma's facilities in Abu Dhabi, the German firm's first such partnership in the Middle East, the company's CEO said.

"The Middle East is very important and the fastest growing region for our products," Stefan Oschmann told reporters. "We plan to meet 100 percent of the regional demand for the products," he added.

Oschmann declined to give specific figures but said revenues from emerging markets accounted for a third of Merck's total.

The two products to be produced at Neopharma's facilities are Euthyrox, a synthetic thyroid hormone and Glucophage, for people suffering from type 2 diabetes.

Production of both branded products will start in 2013.

The UAE suffers from a high prevalence of diabetes. Some 827,000 people between the ages of 20 and 79 have diabetes in the UAE, according to the Ministry of Health.

Treatment of diabetes accounts for about 40 percent of the UAE's overall healthcare expenditure, Amin al Amiri, assistant under-secretary for Medical practice & license at the ministry of health said.

"This alliance will provide increased supply of trusted branded medicines needed to help ease the diabetes crisis which is straining the financial resources of the UAE," he said.

The Middle East is the largest market for Merck's diabetes drug, Glucophage, which is currently imported from Europe.

(Reporting By Stanley Carvalho; Editing by Sami Aboudi and Helen Massy-Beresford)